Conversion From Immediate Release Tacrolimus to Envarsus XR in Simultaneous Pancreas-Kidney Recipients: Assessment of Functional, Safety and Quality of Life Outcomes (CIRTEN SPK)
Phase of Trial: Phase II/III
Latest Information Update: 08 Mar 2019
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary)
- Indications Kidney-pancreas transplant rejection
- Focus Adverse reactions
- Acronyms CIRTEN SPK
- 26 Feb 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 25 Feb 2019 to 5 Mar 2019.
- 15 Feb 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 15 Feb 2019 to 25 Feb 2019.
- 08 Feb 2019 Planned initiation date changed from 1 Feb 2019 to 15 Feb 2019.